Valuation for Private Placement and Preferential Issue under Companies Act, 2013 (Sections 42 & 62): Pricing, Compliance and Practical Insights

Why Valuation Matters in Capital Raising

In today’s capital-driven business environment, valuation plays a central role in determining how companies raise funds, dilute ownership, and attract investors. Whether it is a startup issuing shares to venture capital investors or an established company onboarding strategic partners, pricing of shares must be backed by a robust and defensible share valuation for issue of shares framework.

In practice, valuation for private placement and valuation for preferential issue are among the most common valuation exercises undertaken by private companies, startups, and growth-stage businesses raising capital from investors.

Under the Companies Act, 2013, Sections 42 and 62 govern private placement and preferential issue of shares, respectively. These provisions ensure that capital raising is conducted in a transparent, fair, and compliant manner, protecting the interests of both existing and incoming shareholders.

A well-supported valuation is not merely a pricing exercise—it is a regulatory requirement, a negotiation tool, and a risk mitigation mechanism.

Regulatory Framework Overview

Capital raising through share issuance is primarily governed by Sections 42 and 62 of the Companies Act, 2013, supported by the Companies (Share Capital and Debentures) Rules.

• Section 42 – Private Placement: Deals with issuance of securities to a select group of identified persons and often requires Section 42 private placement valuation support to justify issue pricing.
• Section 62 – Preferential Issue: Covers issuance of shares to specific persons, including existing shareholders or external investors, on a preferential basis and requires Section 62 preferential allotment valuation support for pricing justification.

Both sections operate within a structured compliance ecosystem that includes:

• Rule 13 of Share Capital Rules (pricing and justification)
• Section 247 – mandating valuation by a Registered Valuer in prescribed cases
• Disclosure requirements in explanatory statements and filings

For companies raising funds, especially where pricing is sensitive, these provisions collectively ensure that valuation is fair, justifiable, and aligned with regulatory expectations.

Private Placement under Section 42 – Valuation Perspective

Private placement is one of the most commonly used routes for raising capital in India, particularly by startups and privately held companies.

Although the Companies Act does not prescribe a fixed valuation formula under Section 42, obtaining a valuation report for private placement of shares is considered a governance best practice and is frequently expected by investors, lenders, and transaction advisors.

Under Section 42:

• Securities are offered to a select group of identified persons (maximum 200 in a financial year, excluding QIBs and employees under ESOPs)
• The offer is made through a private placement offer letter (PAS-4)
• Funds are received through banking channels only

From a valuation standpoint, Section 42 does not prescribe a rigid pricing formula. However, in practice, valuation becomes critical for:

• Establishing credibility with investors
• Supporting pricing decisions in board and shareholder approvals
• Aligning with other regulatory frameworks (e.g., FEMA for foreign investments)

Companies typically rely on valuation reports for share issue transactions to justify pricing, especially in institutional funding rounds. While flexibility exists, any arbitrary pricing without a valuation basis can lead to governance concerns and regulatory scrutiny.

Preferential Issue under Section 62 – Pricing & Valuation Rules

Preferential allotment under Section 62 is more structured and places greater emphasis on valuation for preferential issue and valuation-backed pricing.

Key aspects include:

• Shares are issued to a select group of persons, including investors, promoters, or strategic partners
• Pricing must be justified through a valuation report for preferential allotment prepared using accepted valuation methodologies
• Compliance with Rule 13 of Share Capital Rules is mandatory

In practice, Rule 13 preferential allotment valuation compliance is one of the most scrutinized areas during funding rounds, investor due diligence exercises, and regulatory reviews.

Unlike private placement, preferential issues explicitly require that:

• The price of shares is determined based on a valuation report
• The basis of valuation is disclosed in the explanatory statement to shareholders
• The justification for pricing is clearly documented

This ensures that the issuance is not prejudicial to existing shareholders and that dilution happens at a fair value.

In cases involving convertible instruments or related party transactions, valuation becomes even more critical, as regulators closely examine pricing fairness and methodology.

Share Pricing Mechanism – How Valuation is Determined

Determining the price at which shares are issued is both a science and an art. While valuation methodologies provide a structured approach to share valuation for issue of shares, commercial considerations also play a significant role.

Common Valuation Approaches

1. Discounted Cash Flow (DCF) Method

   • Based on projected future cash flows
   • Suitable for high-growth companies and startups

2. Market Multiple / Comparable Method

   • Based on valuation multiples of comparable companies
   • Common in private equity and strategic investments

3. Net Asset Value (NAV) Method

   • Based on underlying asset values
   • Relevant for asset-heavy businesses

Key Factors Influencing Pricing

• Stage of business (startup vs mature company)
• Industry dynamics and growth potential
• Revenue visibility and profitability
• Investor expectations and negotiation power
• Control premium or minority discount

Startup vs Mature Company Pricing

Startups often command higher valuations based on future potential rather than current earnings, whereas mature companies rely more on historical performance and stable cash flows.

The valuation exercise must therefore balance:

• Regulatory defensibility
• Commercial viability
• Investor alignment

A well-documented valuation approach helps bridge this gap and supports smoother negotiations.

Role of Registered Valuer (Section 247)

Section 247 of the Companies Act introduces the concept of a Registered Valuer, who plays a key role in valuation for preferential issue and other corporate transactions requiring independent valuation.

When is a Registered Valuer Required?

• Preferential issue of shares (Section 62)
• Certain corporate restructuring transactions
• Cases where valuation is explicitly mandated under law

Responsibilities of the Registered Valuer

• Selection of appropriate valuation methodology
• Ensuring independence and objectivity
• Providing a reasoned and defensible valuation report for share issue and capital raising transactions
• Documenting assumptions, limitations, and conclusions

Key Components of a Valuation Report for Share Issue Transactions

• Background of the company and transaction
• Purpose of valuation
• Methodology adopted and rationale
• Key assumptions and projections
• Final valuation conclusion

Given increasing regulatory scrutiny, valuation reports must be robust, well-documented, and capable of withstanding audit, tax, and investor review.

Rule 13 Compliance – Key Technical Requirements

Rule 13 of the Companies (Share Capital and Debentures) Rules plays a crucial role in ensuring that preferential issues are compliant and transparent.

Core Requirements

• Special Resolution: Mandatory approval from shareholders
• Explanatory Statement: Must include:
  • Basis of valuation
  • Justification of price
  • Identity of allottees
• Valuation Report: Required to support pricing and establish compliance with Rule 13 preferential allotment valuation requirements

Additional Compliance Aspects

• Filing of MGT-14 with ROC
• Allotment within prescribed timelines
• Filing of PAS-3 (Return of Allotment)

Common Pitfalls

• Inadequate disclosure of the valuation basis for preferential allotment or private placement
• Generic or boilerplate valuation reports
• Delay in filings and procedural lapses
• Misalignment between valuation report and explanatory statement

From a governance perspective, Rule 13 ensures that pricing decisions are transparent and accountable to shareholders.

Conclusion

Valuation for private placement and preferential issue is a critical component of capital raising under the Companies Act, 2013. Sections 42 and 62, read with Rule 13 and Section 247, establish a structured framework that balances fundraising flexibility with regulatory compliance and investor protection.

Whether the transaction involves valuation for private placement, valuation for preferential issue, or broader capital restructuring, companies must ensure that pricing decisions are supported by robust methodologies, transparent assumptions, and professionally prepared valuation reports.

A well-prepared valuation report supported by appropriate methodologies, proper documentation, and regulatory alignment helps companies execute capital raising transactions smoothly while strengthening investor confidence.

At N Pahilwani & Associates, we assist companies with compliant, defensible, and investor-ready valuation reports for private placements, preferential issues, and other capital raising transactions.

Connect with our valuation experts for professional guidance and regulatory compliance support.